Nancy Mitchell, Clinical Nurse Specialist - Psych/Mental Health, Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 140 Glastonbury Blvd, Glastonbury, CT 06033 Phone: 860-559-7034 |
Mary Catherine Lavery, APRN Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 628 Hebron Ave, Glastonbury, CT 06033 Phone: 860-494-4600 |
Renee Provost, APRN Clinical Nurse Specialist - Psych/Mental Health, Geropsychiatric Medicare: Not Enrolled in Medicare Practice Location: 55 Nye Rd Ste 102, Glastonbury, CT 06033 Phone: 860-657-3056 Fax: 860-633-3517 |
Rachel Cohen, Clinical Nurse Specialist - Family Health Medicare: Not Enrolled in Medicare Practice Location: 91 Valley View Rd, Glastonbury, CT 06033 Phone: 860-657-2277 |
News Archive
Down syndrome, the most common chromosomal disorder in America, can be complicated by significant deterioration in movement, speech and functioning in some adolescents and young adults. Physicians previously attributed this regression to depression or early-onset Alzheimer's, and it has not responded to treatments.
Gilead Sciences today announced topline results from two Phase 3 studies, FISSION and NEUTRINO, evaluating a 12-week course of the once-daily nucleotide sofosbuvir in combination with ribavirin (FISSION) and in combination with ribavirin and pegylated interferon (NEUTRINO) among treatment-naïve patients with chronic hepatitis C virus (HCV) infection.
The Assar Gabrielsson Award is given to someone who has written an excellent thesis on cancer research. The 2015 award-winner is Volkan Sayin, and he receives the award for his ground-breaking discoveries about the risks of over-consumption of anti-oxidants.
Researchers at Baylor College of Medicine (BCM) in Houston have reason to believe their unorthodox vaccine could one day help to prevent or control HIV infection, according to a study published in today's edition of Public Library of Science Medicine.
Adimab, Inc., a technology leader in the discovery of fully human antibodies, today announced the initiation of three new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences. Over the past 18 months Adimab has established collaborations with several leading Pharmaceutical companies including: Merck, Roche, Novartis, Pfizer, and now Eli Lilly, Genentech, and Human Genome Sciences.
› Verified 6 days ago